entertainment -WSS

entertainment

author：leisure time 2025-09-30 00:48:16 - browse：187

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： As AI in medicine takes off, can 'human in the loop' prevent harm?

WSS

The real point of Kenneth Smith’s execution by nitrogen gas

Pushing for an NIH office for post

Even great ERs can’t make up for American health disparities

EPA limits use of carcinogenic gas for sterilizing medical devices

The real point of Kenneth Smith’s execution by nitrogen gas

Why depression after traumatic brain injury is distinct

leisure time

entertainment

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

President Biden's budget: Here's what you might have missed

Cancer drug shortages should be causing more outrage

Boston's new lab space is opening empty

Trump demands the U.S. pay no more for drugs than other countries … again

General Catalyst, Summa Health deal will turn on physician buy

How one medical school became remarkably diverse

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Supreme Court strikes down use of affirmative action

Covid misinformation case heads to Supreme Court

Wikipedia

New Ultima Genomics DNA sequencer can read genome for $100

Do digital therapeutics have a future in medicine?

Quicker fix for pulse oximeters urged during FDA public meeting

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Male and female sex labels in research insufficient, scientists say

Apple Vision Pro: A first look at health apps on the new VR headset

focus

entertainment

Wikipedia

Wikipedia